- Global Pharma News & Resources

Mice Model Market Research Report 2021 - Global Forecast to 2026 -

DUBLIN--(BUSINESS WIRE)--The "Mice Model Market based on Type, Service, Technology, Application, and Geography - Global Forecast up to 2026" report has been added to's offering.

The Mice Model Market is projected to grow at the rate of 6.3% CAGR by 2026.

For so many years, mice have been used as models of human biology and disease. Utilizing mice as a model organism to study human biology has been established based on similar physiological and genetic characteristics observed in humans and mice.

Though humans and mice have adapted to different environments through evolution, they have become very different organisms despite their phylogenetic connection. The increasing number of pharmaceutical activities of research and development is expected to propel the market.

The advancements in pharmaceutical drug discovery and development have become moderately more challenging in the past few years. There has been an several number of developments with technology support, which has offered various research procedures by identifying diseases' causes.

On the other hand, for the moral use of animals, the rules and laws in research limit the mice model market's growth.

As per the type, the inbred mice are the most commonly used animals for research by scientists to offer regulated tools for conducting a vast variety of experiments associated with human biology and disease. Also, the growing applications of this type of mice in cardiovascular and immunology studies are the factors to fuel the segment growth further.

In terms of mice model service, the breeding service is leading the mice model market. This segment's leading is majorly ascribed to the factors such as rising demand for mice for drug development and discovery and the upcoming increase in the requirement of personalized medicines worldwide.

Based on technology, the CRISPR/CAS9 segment is expected to hold a significant share of the mice model market. CRISPR/CAS9 technology is most commonly used in the mice model market because it is easy to design, highly efficient, and comparatively less cost, which has further increased this technology's demand.

According to the application of the mice model, it is widely applicable in oncology studies. Since mice are most generally used as the model in human cancer research studies, it has been demonstrated to be a suitable tool as it has comparatively the same genomic and physiological features of tumor biology in mice and humans.

In the mice model market, the North American region has a dominating position in the market share. This is because of the existence of major vendors in the mice model market. The government's increasing investments for the evolution of innovations in mice models are elevating the market growth.

Rising implications of mouse clinical trials (MCTs) for more predictive results are the crucial factor surging the global market growth. Growing demand for personalized medicine, changes in genome engineering tools, and increasing physiological similarities between humans and mice are primary factors that are accelerating the mice model market.

The major leading companies of the mice model market are Taconic Biosciences, Inc., The Jackson Laboratory, Charles River Laboratories, Ingenious Targeting Laboratory, JANVIER LABS, TransCure bioservices, Envigo, genOway, PolyGene, Crown Biosciences, and Cyagen Biosciences.

Key Topics Covered:

1. Executive Summary

2. Industry Outlook

2.1. Industry Overview

2.2. Industry Trends

3. Market Snapshot

3.1. Market Definition

3.2. Market Outlook

3.2.1. Porter Five Forces

3.3. Related Markets

4. Market characteristics

4.1. Market Overview

4.2. Market Segmentation

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. DRO - Impact Analysis

5. Type: Market Size & Analysis

5.1. Overview

5.2. Inbred Mice

5.3. Outbred Mice

5.4. Genetically Engineered Mice

5.5. Hybrid/Congenic Mice

5.6. Others

6. Service: Market Size & Analysis

6.1. Overview

6.2. Breeding

6.3. Cryopreservation

6.4. Model in-Licensing

6.5. Genetic Testing

6.6. Other Services

7. Technology: Market Size & Analysis

7.1. Overview


7.3. Embryonic Stem Cell Injection

7.4. Nuclear Transfer

7.5. Other Technologies

8. Application: Market Size & Analysis

8.1. Overview

8.2. Oncology

8.3. Cardiovascular Studies

8.4. Neurology

8.5. Other Applications

9. Geography: Market Size & Analysis

9.1. Overview

9.2. North America

9.3. Europe

9.4. Asia Pacific

9.5. Rest of the World

10. Competitive Landscape

10.1. Competitor Comparison Analysis

10.2. Market Developments

10.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships

10.2.2. Product Launches and execution

11. Vendor Profiles

11.1. Taconic Biosciences, Inc.

11.1.1. Overview

11.1.2. Financial Overview

11.1.3. Product offerings

11.1.4. Developments

11.1.5. Business Strategy

11.2. The Jackson Laboratory

11.3. Charles River Laboratories

11.4. Ingenious Targeting Laboratory


11.6. TransCure bioservices

11.7. Envigo

11.8. genOway

11.9. PolyGene

11.10. Crown Biosciences

12. Companies to Watch

12.1. Cyagen Biosciences

12.1.1. Overview

12.1.2. Products & Services

12.1.3. Business Strategy

13. Analyst Opinion

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 03-Nov-2021